Iraj Salehi-Abari^1*, Shabnam Khazaeli²

Show more
¹ Rheumatology Research Center, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
² General Practitioner, Genetic Consultant, Toronto, Canada.
Show less

Abstract: COVID-19 is a new contagious, deadly viral/immunological systemic disorder with predominantly respiratory features caused by human infection with SARS-CoV-2, which is rapidly spreading from person-to-person all around the world as a pandemic, whereas, Allergic Rhinitis is an old non-contagious, non-deadly, and non-viral disorder with nasal inflammation which occurs when the immune system overreacts to allergens. Mild to moderate COVID-19 can be mistaken with Allergic Rhinitis. Fever, dry cough, dyspnea, fatigue, body ache, anosmia, and lack of taste are the cardinal feature of COVID-19, whereas runny nose, stuffy nose, sneezing, postnasal discharge, itchy eyes, and itchy skin are the cardinal feature of Allergic Rhinitis. Some of the cardinal feature of COVID-19 can be accessory feature of Allergic Rhinitis and vice versa. These two diseases are usually distinguishable by an expert physician. At the same time, an inexperienced physician will easily confuse them. The known cases of Allergic Rhinitis have allergies in this spring or year similar to previous years, not COVID-19, unless this time the symptoms are sudden, new, or more severe, and with previous conventional allergy treatment; don’t give up and get even worse. In fact, the mission of this article is to provide the easiest way to differentiate these two diseases. In the SARS-CoV-2 epidemics in the Red zones, when we cannot differentiate these two diseases; Allergic Rhinitis should be discarded in favor of COVID-19.

Keywords: COVID-19, Allergic Rhinitis, SARS-CoV-2, RT-PCR

Cite this paper: Salehi-Abari, I. and Khazaeli, S. (2020) COVID-19 versus Allergic Rhinitis. Advances in Infectious Diseases, 10, 168-174. doi: 10.4236/aid.2020.103017.

References

[1]   Coronavirus: Information & Resources, National Jewish Health Coronavirus: Information & Resources. COVID-19 (Coronavirus) Antibody & Molecular Diagnostic Testing Available, 2020.

[2]   CDC (2020) Centers for Disease Control and Prevention CDC 24/7: Saving Lives, Protecting People; Coronavirus COVID-19.

[3]   News Regarding COVID-19 (2020) American Academy of Otolaryngology—Head and Neck Surgery.

[4]   WHO (2020) News and Events Regarding COVID-19 and SARS CoV-2.

[5]   Zhe, X., et al. (2020) Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome. The Lancet, Respiratory Medicine, 8, 420-422.
https://doi.org/10.1016/S2213-2600(20)30076-X

[6]   Gattinoni, L., et al. (2020) COVID-19 Pneumonia: ARDS or Not? Critical Care, 24, Article No. 154.
https://doi.org/10.1186/s13054-020-02880-z

[7]   Sala, S., Peretto, G., et al. (2020) Acute Myocarditis Presenting as a Reverse Tako-Tsubo Syndrome in a Patient with SARS-CoV-2 Respiratory Infection. European Heart Journal, 41, 1861-1862.

[8]   Hua, A., O’Gallagher, K., et al. (2020) Life-Threatening Cardiac Tamponade Complicating Myo-Pericarditis in COVID-19. European Heart Journal, 41, 2130.

[9]   Mubarak, M., et al. (2020) COVID-19 Nephropathy. Journal of Nephropathology, 9, e21.
https://doi.org/10.34172/jnp.2020.21

[10]   Zhang, C., et al. (2020) Liver Injury in COVID-19. The Lancet Gastroenterology & Hepatology, 5, 428-430.
https://doi.org/10.1016/S2468-1253(20)30057-1

[11]   Baig, A.M. (2020) Neurological Manifestations in COVID-19 Caused by SARS-CoV-2.

[12]   Mehta, P., et al. (2020) COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression. The Lancet, 395, 1033-1034.
https://doi.org/10.1016/S0140-6736(20)30628-0

[13]   Vlahovic, T. (2020) COVID-19 Skin Manifestations and the Foot: Podiatry Today.

[14]   Chen, L., et al. (2020) Ocular Manifestations of a Hospitalized Patient with Confirmed COVID-19. British Journal of Ophthalmology, 104, 748-751.

[15]   Green, K., et al. (2020) What Tests Could Potentially Be Used for the Screening, Diagnosis and Monitoring of COVID-19 and What Are Their Advantages and Disadvantages. CEBM; The Centre for Evidence-Based Medicine Develops, Promotes and Disseminates Better Evidence for Healthcare.

[16]   Ding, X., et al. (2020) Chest CT Findings of COVID-19 Pneumonia by Duration of Symptoms. European Journal of Radiology, 127, Article ID: 109009.
https://doi.org/10.1016/j.ejrad.2020.109009

[17]   Small, P. and Kim, H. (2011) Allergic Rhinitis. Allergy, Asthma & Clinical Immunology, 7, S3.
https://doi.org/10.1186/1710-1492-7-S1-S3

[18]   Rhinitis, A. (2014) American College of Allergy, Asthma & Immunology.

[19]   Rhinitis, A. (2019) NHS Sites.

[20]   Sood, A. (2005) Diagnostic Significance of Nasal Eosinophilia in Allergic Rhinitis. Indian Journal of Otolaryngology and Head & Neck Surgery, 57, 13-16.

[21]   Sheikh, J., Kaliner, M.A., et al. (2018) What Is the Role of Blood Eosinophil Count in the Diagnosis of Allergic Rhinitis. Medscape.

[22]   Giacomelli, A., et al. (2020) Self-Reported Olfactory and Taste Disorders in SARS-CoV2 Patients. Clinical Infectious Disorder, 71, 889-890.